You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 翰宇藥業(300199.SZ)午後直線拉漲逾3% 醋酸阿託西班注射液6.75mg獲得德國藥品上市許可
格隆匯 05-06 13:18
格隆匯5月6日丨翰宇藥業(300199.SZ)午後直線拉昇,現報5.77元,漲3.22%,暫成交3083萬元,最新總市值52.9億元。翰宇藥業今日午間公佈,公司的醋酸阿託西班注射液6.75mg近日收到了德國聯邦藥品和醫療器械研究所的上市許可。公司表示,此次收到上市許可,標誌着公司該規格產品具備了在德國上市的資格,對公司產品在德國市場的推廣具有積極影響。公司該藥品37.5mg/5ml規格產品的上市許可也已在德國國家階段的批件審核發放階段。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account